{"symbol": "GEMP", "companyName": "Gemphire Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.gemphire.com", "description": "Gemphire Therapeutics Inc is a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease.", "CEO": "Steven R. Gullans", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}